Recent Comments

    Social menu is not set. You need to create menu and assign it to Social Menu on Menu Settings.

    Nation

    1 min read

    Hours after Prime Minister Narendra Modi visited Pune-based pharma company Serum Institute of India (SII) on Saturday (November 28), the company's CEO Adar Poonawalla said...

    1 min read

    India's remote sensing satellite CARTOSAT-2F in Earth's orbit, Russia's Earth Observation Satellite has come very close to Kanopus-V. The space research organizations of both countries are...

    1 min read

    The dispute between India and China in eastern Ladakh is not over yet. The forces of the two countries are face to face on the LAC. The...

    1 min read

    Jammu and Kashmir recorded 22.12 per cent votes polled till 11 am across Jammu and Kashmir in the first phase of District Development Council (DDC)...

    1 min read

    As the poll pitch gathers steam ahead of Hyderabad civic polls, Uttar Pradesh Chief Minister Yogi Adityanath is visiting Hyderabad today to add firepower to...

    November 29, 2020

    PM Modi reviews status of India’s Covid-19 vaccine development efforts

    1 min read

    iSpeech

    Prime Minister Narendra Modi on Tuesday chaired a meeting of the task force on coronavirus vaccine development. PM Modi also took a detailed review of the current status of ’s steady efforts in vaccine development, drug discovery, diagnosis and testing.

    According to a statement released by the prime minister’s office, Indian vaccine companies have come across as innovators in early stage vaccine development research.The PMO has also noted contributions of Indian academia and start-ups pioneering the domain. Over 30 Indian vaccines are in different stages of vaccine development,with few going on to trial stages. PM felt that such coordination and speed should be embedded into a standard operating procedure

    It was also observed that with linkage of laboratories all over the country, capacity for both — RT-PCR approach and for the antibody detection — have been enormously scaled up.

    “The problem of importing reagents for testing has been addressed by consortia of Indian start-ups and industry, meeting current requirements. The current thrust also holds promise for the development of a robust long-term industry in this area,” the statement read.

    Leave a Reply

    Your email address will not be published. Required fields are marked *